With a pipeline of 77 clinical trials, we have placed ourselves among the reference groups in oncology at a national and international level.
We are already more than 400 members and we have a network of more than 100 active sites in Spain and Portugal.
We organize activities to bring new knowledge to researchers and promote networking.
We are committed to empowering patients to address their disease.
Currently 60% of our pipeline are trials promoted by the group
With a traslational-basis, our trials are grouped under three programs:
Phase I, II and III classical trials, proof-of-concept. Involving quite a large period of time, they give us information on a drug’s efficacy.
Trials with no drug-intervention. Samples collection + correlative analysis of tumors and liquid biopsies. Looking for clinically-predictive biomarkers and mechanisms of resistance.
Very informative trials at a biological level. They take advantage of the period between the diagnosis and surgery to test new therapeutic strategies.
No membership fee is required.
Boosts clinical research
Contribute